Exhibit 10.3
February 4, 2011
Spero Pain Relief Therapy, LLC
348 E. 600 S.
St. George, UT 84770
RE: Amendment to Sales Agreement Between Competitive Technologies, Inc. and Spero Pain Relief Therapy, LLC, dated September 30, 2010
Dear Mr. Miller and Dr. Chalmers,
Based on our discussions, we are pleased amend our agreement with you which is dated September 30, 2010 as follows:
1.
Spero Pain Relief Therapy, LLC ("Spero"), and its affiliates will, in selected areas, establish 18 treatment centers utilizing Competitive Technologies, Inc.'s ("CTTC") Calmare® Pain Therapy Treatment medical device, model MC-5A. The original agreement was for 14 clinics. The 4 additional clinics are in[Confidential Information Omitted].
2.
Schedule A-1 is amended to include the zip codes for[Confidential Information Omitted]on Amended Schedule B. Continued exclusivity is predicated on Spero's purchase or lease of the minimum number of devices indicated on Schedule B.
3.
The exclusivity conditions, pricing for devices, supplies and training, as well as warranty provisions of the original agreement remain in place.
4.
This agreement is transferable and binding upon any new owners in the event of the change of control or ownership of either CTTC or Spero.
We at Competitive Technologies look forward to a long and mutually beneficial business relationship with Spero Pain Relief Therapy over the coming months and years.
Sincerely,
_______________________________________
_______________________________________
Johnnie D. Johnson
Signature Spero Pain Relief Therapy, LLC
Chief Executive Officer
Printed Name
__________________________
Competitive Technologies, Inc.
Date
__________________________
_______________________________________
Signature Spero Pain Relief Therapy, LLC
Printed Name
__________________________
Date
__________________________
*Confidential information on this page has been omitted Pursuant to Rule 24b-2,
and has been filed separately with the Securities and Exchange Commission*
CTTC8K5414
Schedule A-1 – Spero/CTTC Sales Agreement, Amended January 26, 2011
Spero Pain Relief Therapy Defined Zip Codes
[Confidential Information Omitted]
*Confidential information on this page has been omitted Pursuant to Rule 24b-2,
and has been filed separately with the Securities and Exchange Commission*
CTTC8K5415
Schedule B-1, Spero/CTTC Sales Agreement, Amended January 26, 2011
Device Plan for Selected Office Locations, by Region
[Confidential Information Omitted]
*Confidential information on this page has been omitted Pursuant to Rule 24b-2,
and has been filed separately with the Securities and Exchange Commission*
CTTC8K5416
Schedule B-1, Spero/CTTC Sales Agreement, Amended January 26, 2011
Device Plan for Selected Office Locations, by Region
[Confidential Information Omitted]
*Confidential information on this page has been omitted Pursuant to Rule 24b-2,
and has been filed separately with the Securities and Exchange Commission*
CTTC8K5417
Schedule B-1, Spero/CTTC Sales Agreement, Amended January 26, 2011
Device Plan for Selected Office Locations, by Region
[Confidential Information Omitted]
*Confidential information on this page has been omitted Pursuant to Rule 24b-2,
and has been filed separately with the Securities and Exchange Commission*
CTTC8K5418
